Sopharma's sales revenue rose by 6% to over 167 mln leva in 2008. The sales revenue from exports went up by 14%, while the sales on the domestic market declined by 6%, the company said through x3news.

Sopharma booked more than 15 mln leva sales in December, which represents a 10-percent year-on-year decline. The exports of the company shrunk by 23% last month, while the sales on the domestic market increased by 2%.

The company posted 15.7 mln leva sales in November, down by 5% compared to the same month in 2007.

Sopharma's sales for the first eleven months of 2008 rose by 7.7%, compared to the year-ago period, including a 17.9-percent increase in exports and a 7-percent decline in domestic sales.

The sales revenue of the company for the first nine months of the year went up by 9%, including a 22-percent rise in exports.

Sopharma's stock appreciated by 0.09%, to 2.27 leva per share on the Bulgarian Stock Exchange (BSE) yesterday. The traded volume on the position came to 5,946 shares.